| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.968 | 383 | 0 | 0 | 0 | 0 | 1.021 | 3.184 | 3.164 | 4.051 |
| Total Income - EUR | 6.049 | 383 | 0 | 0 | 0 | 0 | 1.021 | 3.184 | 3.164 | 4.051 |
| Total Expenses - EUR | 2.757 | 317 | 0 | 0 | 0 | 0 | 890 | 1.571 | 3.865 | 11.106 |
| Gross Profit/Loss - EUR | 3.292 | 66 | 0 | 0 | 0 | 0 | 130 | 1.612 | -701 | -7.055 |
| Net Profit/Loss - EUR | 3.110 | 54 | 0 | 0 | 0 | 0 | 99 | 1.517 | -760 | -7.177 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Nectaria Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 438 | 131 | 128 | 126 | 124 | 121 | 119 | 119 | 119 | 118 |
| Current Assets | 3.389 | 358 | 352 | 345 | 339 | 332 | 454 | 968 | 1.283 | 28 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 172 | 358 | 352 | 345 | 339 | 332 | 454 | 968 | 1.283 | 28 |
| Shareholders Funds | -12.115 | -11.937 | -11.735 | -11.520 | -11.296 | -11.082 | -10.737 | -9.254 | -9.985 | -17.106 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.942 | 12.425 | 12.215 | 11.991 | 11.759 | 11.536 | 11.309 | 10.340 | 11.387 | 17.252 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nectaria Med Srl